Published in Intensive Care Med on January 01, 1986
Right ventricular dysfunction in patients with septic shock. Intensive Care Med (1988) 0.85
Methods of monitoring shock. Semin Respir Crit Care Med (2004) 0.80
Right ventricular performance in patients with acute respiratory failure. Intensive Care Med (1988) 0.78
The right ventricle and critical illness: a review of anatomy, physiology, and clinical evaluation of its function. Intensive Care Med (1988) 0.77
The effect of milrinone on the right ventricular function in patients with reduced right ventricular function undergoing off-pump coronary artery bypass graft surgery. J Korean Med Sci (2006) 0.77
The influence of catecholamines on right ventricular function in septic shock. Intensive Care Med (1988) 0.75
Right ventricular ejection fraction measurement in moderate acute respiratory failure (ARF). Effects of PEEP. Intensive Care Med (1988) 0.75
Right ventricular performance during hypotension induced by prostaglandin E1, nicardipine HCl, glycerine trinitrate, and isosorbide dinitrate. J Anesth (1997) 0.75
Preliminary pulsatile flow bench validation of a thermodilution right ventricular ejection fraction system. Intensive Care Med (1988) 0.75
Pressure and volume assessment of right ventricular function during mechanical ventilation. Intensive Care Med (1988) 0.75
Right ventricular function in septic shock. Intensive Care Med (1988) 0.75
Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med (2001) 27.70
Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA (2001) 10.03
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med (1997) 4.86
Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med (2000) 4.74
Isolation of an Escherichia coli K-12 mutant strain able to form biofilms on inert surfaces: involvement of a new ompR allele that increases curli expression. J Bacteriol (1998) 4.33
Abiotic surface sensing and biofilm-dependent regulation of gene expression in Escherichia coli. J Bacteriol (1999) 4.26
The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med (1999) 3.93
Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg (1996) 3.31
Has the mortality of septic shock changed with time. Crit Care Med (1998) 3.29
Erythropoietin response is blunted in critically ill patients. Intensive Care Med (1997) 3.20
Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med (1999) 2.93
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med (1993) 2.84
Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest (1993) 2.79
Sedative and analgesic practice in the intensive care unit: the results of a European survey. Br J Anaesth (2001) 2.75
A profile of European intensive care unit physiotherapists. European Society of Intensive Care Medicine. Intensive Care Med (2000) 2.72
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study. Crit Care Med (2001) 2.56
Developmental pathway for biofilm formation in curli-producing Escherichia coli strains: role of flagella, curli and colanic acid. Environ Microbiol (2000) 2.56
Methylene blue administration in septic shock: a clinical trial. Crit Care Med (1995) 2.50
Predictive value of microalbuminuria in medical ICU patients: results of a pilot study. Chest (2001) 2.43
Complex regulatory network controls initial adhesion and biofilm formation in Escherichia coli via regulation of the csgD gene. J Bacteriol (2001) 2.35
The hepatosplanchnic area is not a common source of lactate in patients with severe sepsis. Crit Care Med (2001) 2.34
An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit Care Med (1999) 2.33
Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis (1999) 2.32
Physiotherapy for adult patients with critical illness: recommendations of the European Respiratory Society and European Society of Intensive Care Medicine Task Force on Physiotherapy for Critically Ill Patients. Intensive Care Med (2008) 2.31
Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest (1991) 2.25
The H-NS protein is involved in the biogenesis of flagella in Escherichia coli. J Bacteriol (1994) 2.24
Relation between oxygen consumption and oxygen delivery in patients after cardiac surgery. Anesth Analg (1993) 2.12
Chromosome transfer and R-prime plasmid formation mediated by plasmid pULB113 (RP4::mini-Mu) in Alcaligenes eutrophus CH34 and Pseudomonas fluorescens 6.2. J Bacteriol (1983) 2.12
Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest (1997) 2.07
Interleukin-10 production during septicaemia. Lancet (1994) 2.05
How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage. Crit Care Med (1997) 2.03
Relationship between oxygen uptake and oxygen delivery in septic patients: effects of prostacyclin versus dobutamine. Crit Care Med (1993) 2.00
Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock. Crit Care Med (1995) 1.97
Serial lactate determinations during circulatory shock. Crit Care Med (1983) 1.93
European participation in major intensive care journals. Intensive Care Med (1995) 1.93
Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure. Crit Care Med (2000) 1.84
Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol (2005) 1.83
Involvement of the Cpx signal transduction pathway of E. coli in biofilm formation. FEMS Microbiol Lett (1999) 1.83
Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy. Neurology (2008) 1.78
The role of carbohydrates in the induction of flowering in Arabidopsis thaliana: comparison between the wild type and a starchless mutant. Planta (1998) 1.77
Effects of vasoactive drugs on gastric intramucosal pH. Crit Care Med (1998) 1.77
Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med (2000) 1.70
Application of SOFA score to trauma patients. Sequential Organ Failure Assessment. Intensive Care Med (1999) 1.66
Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial. J Trauma (1997) 1.64
Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg (1996) 1.63
The Brussels sedation scale: use of a simple clinical sedation scale can avoid excessive sedation in patients undergoing mechanical ventilation in the intensive care unit. Br J Anaesth (1999) 1.63
Hemodynamic responses to successful weaning from mechanical ventilation after cardiovascular surgery. Intensive Care Med (2000) 1.62
Estimating left ventricular filling pressure during positive end-expiratory pressure in humans. Am Rev Respir Dis (1991) 1.61
Effects of propofol on human microcirculation. Br J Anaesth (2008) 1.56
Uric acid, anion gap and urea concentration in the diagnostic approach to hyponatremia. Clin Nephrol (1994) 1.54
Correlation of serial blood lactate levels to organ failure and mortality after trauma. Am J Emerg Med (1995) 1.53
Haemodynamic evaluation of pulmonary hypertension. Eur Respir J (2002) 1.53
Do established prognostic factors explain the different mortality rates in ICU septic patients around the world? Minerva Anestesiol (2012) 1.53
Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance. J Clin Microbiol (1997) 1.51
A Xanthomonas campestris pv. campestris protein similar to catabolite activation factor is involved in regulation of phytopathogenicity. J Bacteriol (1990) 1.51
Systemic vascular effects of isoflurane versus propofol anesthesia in dogs. Anesth Analg (1996) 1.48
Sepsis, severe sepsis or sepsis syndrome: need for clarification. Intensive Care Med (1992) 1.48
Coagulopathy induced by hydroxyethyl starch. Anesth Analg (1997) 1.47
Roundtable Conference on Clinical Trials for the Treatment of Sepsis. Brussels, March 12-14, 1994. Chest (1995) 1.47
Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Nephrol Dial Transplant (2000) 1.46
Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea. Am J Med (1980) 1.44
Hypertonic saline solution-hetastarch for fluid resuscitation in experimental septic shock. Anesth Analg (1989) 1.44
Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation. J Thorac Cardiovasc Surg (1992) 1.42
Doctors' perceptions of the effects of interventions tested in prospective, randomised, controlled, clinical trials: results of a survey of ICU physicians. Intensive Care Med (2001) 1.41
Diagnosis and treatment of an unusual cause of metabolic acidosis: ethylene glycol poisoning. Acta Clin Belg (1999) 1.40
Addition of enoximone to adrenergic agents in the management of severe heart failure. Crit Care Med (1992) 1.40
Bretylium tosylate versus lidocaine in experimental cardiac arrest. Am J Emerg Med (1990) 1.39
Thermodilution for measurement of cardiac output during artificial ventilation. Intensive Care Med (1988) 1.39
Atropine administration in experimental electromechanical dissociation. Am J Emerg Med (1992) 1.39
Administration of dopexamine, a new adrenergic agent, in cardiorespiratory failure. Chest (1989) 1.38
Cardiac tamponade due to spontaneous rupture of right coronary artery aneurysm. Ann Thorac Surg (1996) 1.37
The major portal of entry of koi herpesvirus in Cyprinus carpio is the skin. J Virol (2009) 1.34
Effects of nitric oxide in septic shock. Am J Respir Crit Care Med (2000) 1.27
Veno-arterial carbon dioxide gradient in human septic shock. Chest (1992) 1.26
Is outcome from ARDS related to the severity of respiratory failure? Eur Respir J (1997) 1.25
Lactate production by the lungs in acute lung injury. Am J Respir Crit Care Med (1997) 1.25
Mutations in bglY, the structural gene for the DNA-binding protein H1, affect expression of several Escherichia coli genes. Biochimie (1990) 1.25
Shuttle transfer (or retrotransfer) of chromosomal markers mediated by plasmid pULB113. Mol Gen Genet (1987) 1.24
Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg (1996) 1.14
A profile of European ICU nursing. Intensive Care Med (1998) 1.13
Leukocyte glycolysis and lactate output in animal sepsis and ex vivo human blood. Metabolism (1999) 1.10
Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study. Chest (1992) 1.10
Blood interleukin 10 levels parallel the severity of septic shock. J Crit Care (1997) 1.09
Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis. Crit Care Med (1995) 1.09